Evidence map›Paper›PMID 42589317›Full record

ArticleInternational journal of molecular sciences2026

Bacterioruberin from

Andrés Baeza-Morales, Sandra Pascual-García, Pascual Martínez-Peinado, Alicia Navarro-Sempere, Yolanda Segovia, Miguel Medina-García, Carolina Pujalte-Satorre, Rúben Rodrigues, Magdalena García, Rosa María Martínez-Espinosa and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrés Baeza-MoralesImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-3270-307X
Sandra Pascual-GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0002-0536-1185
Pascual Martínez-PeinadoImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-4370-5468
Alicia Navarro-SempereImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.
Yolanda SegoviaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-1727-2603
Miguel Medina-GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0009-0006-1924-8729
Carolina Pujalte-SatorreImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.
Rúben Rodriguesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0009-0007-5491-0770
Magdalena GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0002-6823-4781
Rosa María Martínez-EspinosaBiochemistry and Molecular Biology and Edaphology and Agricultural Chemistry Department, Faculty of Sciences, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-2679-135X
M Helena Vasconcelosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-7801-4643
José Miguel Sempere-OrtellsImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0001-5439-0604

Funding

Generalitat Valenciana PROMETEO/2021/055Ministry of Science, Innovation and Universities FPU21/02299
6 · The paper itself

Abstract

Bacterioruberin (BR), a C

Indexed as

Antineoplastic AgentsCarotenoidsHaloferax mediterraneiA549 CellsApoptosisCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmDrug Screening Assays, AntitumorHumansLung NeoplasmsAntineoplastic AgentsbacterioruberinCarotenoidsapoptosisbacterioruberinHaloferax mediterraneimultidrug resistanceoxidative stressP-glycoprotein

Identifiers

PMID42589317
PMCPMC13467541

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.